Stocks
Snap-on (SNA) to Report Q4 Earnings: Investors Keep Watch
Snap-on (SNA) to Report Q4 Earnings: Investors Keep Watch
—
Snap-on Incorporated is expected to release its fourth-quarter 2023 results on Feb 8, before the market opens. Investors are eagerly awaiting the impending financial ...
ExxonMobil Reports Q4 Earnings Performance Amid Lower Revenues
—
Exxon Mobil Corporation XOM delivered fourth-quarter 2023 earnings per share of $2.48 (excluding identified items), surpassing the Zacks Consensus Estimate of $2.21. Despite this, ...
A Beneath-The-Surface Look at Aspen Technology’s Anticipated Q2 Earnings Report
—
Aspen Technology AZPN looks all set to unravel its second-quarter fiscal 2024 results on Feb 6. An analysis of the Zacks Consensus Estimate for ...
Fed Pause Has Tightened Monetary Policy
—
Fed’s Monetary Policy Tightens Amidst Uncertainty of Rate Cuts Fed’s March Rate Cut Markets were disappointed by Chair Powell saying March is not the Fed’s base ...
Chevron Corporation Financial Insight
Assessing the Future of CVX Stock After a Troubling Year
—
Chevron Corporation (NYSE: CVX), a prominent player in the refined petroleum products industry, is gearing up to disclose its fiscal fourth-quarter results on February ...
3 Value Stocks That Surpassed Q4 Earnings Estimates
3 Value Stocks That Surpassed Q4 Earnings Estimates
—
In a week packed with quarterly results from big tech firms, several top-rated Zacks stocks across various sectors have stood out. Stronger-than-expected Q4 earnings ...
Insight Into Meta and Apple Shares
Insight Into Meta and Apple Shares
—
Earnings season always gives investors a behind-the-scenes look at companies, making the 2023 Q4 cycle especially critical as a harbinger of what lies ahead ...
Labcorp’s Groundbreaking Test for Preeclampsia in Pregnant Women
Labcorp’s Groundbreaking Test for Preeclampsia in Pregnant Women
—
Laboratory Corporation of America Holdings, Inc., commonly known as Labcorp (LH), has made a significant stride with the introduction of an innovative, FDA-cleared blood ...
Roche’s Revenue Miss Reflects COVID-19 Testing Challenges
—
Roche’s performance in 2023 saw a dip primarily due to a decline in COVID-19 test sales and exchange rate volatility, while newer drugs and ...
Stanley Black Struggles with Weak Tools & Outdoor Segment in Q4 Sales Report
—
Stanley Black & Decker, Inc. SWK revealed fourth-quarter 2023 adjusted earnings of 92 cents per share, surpassing the Zacks Consensus Estimate of 73 cents ...
